Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine

Clinical trial NCT00103467 · COMPLETED

Trial details

NCT number: NCT00103467
Sponsor: VaxGen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prevention of Anthrax Infection

Start date: 2003-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.